Radiosurgery or hypofractionated stereotactic radiotherapy for brain metastases from radioresistant primaries (melanoma and renal cancer)

BACKGROUND: Until 50% of patients with renal cancer or melanoma, develop brain metastases during the course of their disease. Stereotactic radiotherapy has become a standard of care for patients with a limited number of brain metastases. Given the radioresistant nature of melanoma and renal cancer,...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Radiat Oncol
Asıl Yazarlar: Lesueur, Paul, Lequesne, Justine, Barraux, Victor, Kao, William, Geffrelot, Julien, Grellard, Jean-Michel, Habrand, Jean-Louis, Emery, Evelyne, Marie, Brigitte, Thariat, Juliette, Stefan, Dinu
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioMed Central 2018
Konular:
Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6064124/
https://ncbi.nlm.nih.gov/pubmed/30055640
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13014-018-1083-1
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller